Trinity Biotech plc announced that Mr. John Gillard, Group Chief Financial Officer, has informed the Board of Directors of the Company of his intention to resign in order assume a senior finance role in an organisation outside the life sciences sector. Mr. Gillard is expected to leave Trinity Biotech in April 2022 and a process to appoint his successor will now commence.